SCHEMBL4356052

SCHEMBL4356052

C=CCOC(=O)N[C@@H](COCc1ccccc1)C(=O)NCC(=O)N(CCC(=O)CNC(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](CC(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.39
PTPN1 P18031 8/20 0.39
TNF P01375 1/20 0.35
PPARA Q07869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356049 1.00 CTSS (0.39) CTSSPTPN1TNFPPARA
SCHEMBL4348014 0.91 CTSS (0.46) CTSSPPARA
SCHEMBL4348011 0.91 CTSS (0.46) CTSSPPARA
SCHEMBL13613768 0.88 PTPN1 (0.36) CTSSPTPN1
SCHEMBL4344615 0.88 PTPN1 (0.36) CTSSPTPN1TNFPPARA
SCHEMBL13613758 0.76 PTPN1 (0.41) PTPN1
SCHEMBL4351945 0.76 PTPN1 (0.36) CTSSPTPN1PPARA
SCHEMBL13613765 0.75 SYK (0.46) CTSS
SCHEMBL2583829 0.73 PPARA (0.55) CTSSTNFPPARA
SCHEMBL28430224 0.73 PPARA (0.55) CTSSTNFPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275727-A1 Peptide turn mimetics MIMETICA PTY LIMITED (AU) 2009-11-05 US disclosed
US-20090275727-A1 Peptide turn mimetics MIMETICA PTY LIMITED (AU) 2009-11-05 US disclosed
US-20090275727-A1 Peptide turn mimetics MIMETICA PTY LIMITED (AU) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275727-A1 Peptide turn mimetics IAPP, GLP1R, VIP CTSS 1601/4885PTPN1 2158/4885TNF 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.